These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33270606)

  • 1. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice.
    Harro CM; Perez-Sanz J; Costich TL; Payne KK; Anadon CM; Chaurio RA; Biswas S; Mandal G; Rigolizzo KE; Sprenger KB; Mine JA; Showe LC; Yu X; Liu K; Rodriguez PC; Pinilla-Ibarz J; Sokol L; Conejo-Garcia JR
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33270606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
    Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
    J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNF5 deficiency induces apoptosis resistance by repressing SATB1 expression in Sézary syndrome.
    Li Y; Wang J; Yu M; Wang Y; Zhang H; Yin J; Li Z; Li T; Yan H; Li F; Wang X
    Leuk Lymphoma; 2018 Oct; 59(10):2405-2413. PubMed ID: 29334836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription.
    Wang Y; Su M; Zhou LL; Tu P; Zhang X; Jiang X; Zhou Y
    Blood; 2011 Apr; 117(14):3826-35. PubMed ID: 21270445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of SATB1 expression with clinical course of cutaneous T-cell lymphomas.
    Grzanka A; Grzanka D; Gagat M; Tadrowski T; Sokołowska-Wojdyło M; Marszałek A; Placek W
    Pol J Pathol; 2012 Jun; 63(2):101-5. PubMed ID: 22864778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SATB1 Defines a Subtype of Cutaneous CD30
    Sun J; Yi S; Qiu L; Fu W; Wang A; Liu F; Wang L; Wang T; Chen H; Wang L; Kadin ME; Tu P; Wang Y
    J Invest Dermatol; 2018 Aug; 138(8):1795-1804. PubMed ID: 29510190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SATB1 in Malignant T Cells.
    Fredholm S; Willerslev-Olsen A; Met Ö; Kubat L; Gluud M; Mathiasen SL; Friese C; Blümel E; Petersen DL; Hu T; Nastasi C; Lindahl LM; Buus TB; Krejsgaard T; Wasik MA; Kopp KL; Koralov SB; Persson JL; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Becker JC; Ødum N
    J Invest Dermatol; 2018 Aug; 138(8):1805-1815. PubMed ID: 29751003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB1-mediated chromatin landscape in T cells.
    Zelenka T; Spilianakis C
    Nucleus; 2020 Dec; 11(1):117-131. PubMed ID: 33356851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Bieniek A; Dziegiel P
    Anticancer Res; 2016 Jan; 36(1):189-97. PubMed ID: 26722043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome.
    Miyashiro D; Souza BCE; Torrealba MP; Manfrere KCG; Sato MN; Sanches JA
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-positive CD4(+)CD8(+) Sézary syndrome: an unusual phenotype with an aggressive clinical course.
    Wu R; Zippin JH; Magro C
    Cutis; 2014 Feb; 93(2):E18-25. PubMed ID: 24605355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of special AT-rich sequence-binding protein 1 is an independent prognostic factor in cutaneous T-cell lymphoma.
    Grzanka D; Gagat M; Izdebska M; Marszałek A
    Oncol Rep; 2015 Jan; 33(1):250-66. PubMed ID: 25384658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment in mycosis fungoides and Sézary syndrome.
    Rubio Gonzalez B; Zain J; Rosen ST; Querfeld C
    Curr Opin Oncol; 2016 Jan; 28(1):88-96. PubMed ID: 26632770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
    Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
    J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the cutaneous peripheral T-cell lymphomas: when subtypes matter.
    Choi MY; Lechowicz MJ
    Cancer J; 2012; 18(5):439-44. PubMed ID: 23006949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics of Cutaneous T-Cell Lymphomas.
    Hara N; Sawada Y
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.
    van der Fits L; van Kester MS; Qin Y; Out-Luiting JJ; Smit F; Zoutman WH; Willemze R; Tensen CP; Vermeer MH
    J Invest Dermatol; 2011 Mar; 131(3):762-8. PubMed ID: 21085192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors.
    Campbell JJ; Clark RA; Watanabe R; Kupper TS
    Blood; 2010 Aug; 116(5):767-71. PubMed ID: 20484084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Response to tenalisib and romidepsin with long-term maintenance using tenalisib monotherapy in a patient with relapsed and refractory sézary syndrome.
    Nguyen CN; Iyer SP; Duvic M; Barde PJ; Nair A; Routhu KV; Huen AO
    Invest New Drugs; 2023 Apr; 41(2):350-355. PubMed ID: 37004644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.